Patient Centered Care

Social prescribing is not yet part of Portugal's national health system. Economists are asking whether it works, and who pays for it.

BioNTech's AHEAD-MERIT trial did not reach significance on progression-free survival. The overall survival read-out is still to come.

OHE's A Dose of Economics explores why medicines made for one patient challenge regulation, payment and HTA.

WHO and St. Jude, with UNICEF and PAHO, have launched a 2026 to 2030 market-shaping strategy to improve access to childhood cancer medicines in low- and middle-income countries. #SyenzaNews #ChildhoodCancer #MarketAccess #Oncology

CTS's Global Horizon panel brought four US operators to Montréal to explain why the US healthcare market rewards commercial readiness over good technology, and what founders can do about it. #SyenzaNews #MarketAccess #HealthTech

A new benchmark in npj Digital Medicine finds frontier AI models at near-perfect accuracy on German medical licensing exams, yet image questions still cut their scores far more than for students. #SyenzaNews #AIinHealthcare #DigitalHealth

Finland, UNRISD and the WHO asked what the Economics of Health for All strategy means for the next generation, from intergenerational fairness and participatory foresight to dignified access to care. #SyenzaNews #HealthEconomics #WellbeingEconomy

A new consensus framework grades dehiscence, infection, seroma, and haematoma in a single score, with strong agreement across 60 specialists.

What if blending ICU clinician models delivers the best patient outcomes? A new analysis comparing staffing approaches reveals that hybrid models—merging physician-led oversight with advanced practice provider expertise—outperform traditional structures in efficiency, cost, and care quality. Explore the full findings and see how this evidence can guide your ICU strategy. #SyenzaNews #healthcare #HealthcareInnovation #innovation #strategicplanning

💊 What does South Africa’s approval of generic semaglutide mean for patients and payers? Following patent expiration, the green light for generic versions promises lower costs and wider access to this key treatment for type 2 diabetes and weight management. Explore how this decision could reshape market access and affordability across emerging economies. #SyenzaNews #pharmaceuticals #drugdevelopment #MarketAccess #costeffectiveness

📊 How is Portugal turning hospital data into powerful population health insights? A new data platform is enabling deeper analysis of health trends, outcomes, and resource use across patient populations. Explore how this approach is advancing data-driven decision-making in healthcare. #SyenzaNews #digitalhealth #HealthTech #DigitalTransformation #datascience

🤖 How is Europe ensuring AI enhances healthcare without replacing human judgment? European health systems are embedding AI tools across diagnostics, treatment planning, and operations while mandating clinician oversight to maintain safety, ethics, and trust. This balanced approach is shaping the next phase of responsible digital health adoption. Read the full analysis to see what this means for providers and policymakers. #SyenzaNews #AIinHealthcare #HealthcareInnovation #ai #DigitalTransformation